FIBRONECTINBINDENDE PEPTIDE ZUR VERWENDUNG BEI DER DIAGNOSE EINES TUMORS ODER VON FIBROSE UND THERAPIE

European patent · EP3472190 · In force

Register entry

Publication number
EP3472190
Application number
EP17731525
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 14, 2017
Published
Apr 24, 2019
Granted
Oct 11, 2023
Protection ends at the latest
Jun 13, 2037
Next annual fee due
Jun 30, 2027
IPC classes
C07K 14/435 (2006.01)
A61P 1/16 (2006.01)
A61P 3/10 (2006.01)
A61P 9/10 (2006.01)
A61P 11/00 (2006.01)
A61P 13/12 (2006.01)
A61P 19/02 (2006.01)
A61P 29/00 (2006.01)
A61P 35/00 (2006.01)
A61P 35/02 (2006.01)
A61P 37/02 (2006.01)
A61P 37/06 (2006.01)
A61P 43/00 (2006.01)
Priority
EP 16174824 16.06.2016
PCT application
PCT/EP2017/064543 14.06.2017
PCT publication
WO2017/216223 21.12.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Aug 21, 2024

    Change

    Published in Swissreg on 21.08.2024

  4. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  5. Nov 16, 2023

    Agent entered

    Representative
    Vossius & Partner, Patentanwälte Rechtsanwälte mbB, Hirschgässlein 11, 4051 Basel

    Published in Swissreg on 16.11.2023

  6. Oct 11, 2023

    Granted

    Published in Swissreg on 11.10.2023

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.